A Pilot Phase II Trial of Cabergoline in the Treatment of Metastatic Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Cabergoline (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 13 Dec 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2018.